Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Almac Group Invests US$ 84.7 million (£80 million) to Open Manufacturing Facility in Ireland
The Almac Group plans to invest US$ 847 million 80 million in building new extensive manufacturing, production, and diagnostic laboratory facilities in Craigavon, Northern Ireland
University of Pittsburgh Plans to Construct Bio manufacturing Centre in USA
The Universitys plan to construct a stateoftheart life sciences facility This centre will serve as a hub for life sciences and biotechnology research
Roswell Park Comprehensive Cancer Centre Invests US$98 million to Open Cell and Gene Therapy Hub in New York, USA
Roswell Park Comprehensive Cancer Centre invests US$98 million to open cell and gene therapy manufacturing facility in USA
Syngene Invests US$9.5 (INR 788 crores) to Open New Facility in India
Syngene with an investment of US$95 INR 788 crores plans to build new stateoftheart research laboratories in Hyderabad, India This will be an extension to its existing research campus
Aenova Invests US$10.5 million (10 million Euros) to Enhance its Production Capacity in Italy
Aenova invests around US$105 million 10 million Euros in additional production capacity for semisolids and nonsterile liquids at their Carugate site, Italy
MD Anderson Breaks Ground on US$668 million New Research Facility in USA
The University of Texas MD Anderson Cancer Center with an investment of US$668 plans for the new cuttingedge research campus
Bigelow Laboratory Invests US$30 million to Open New Centre in Maine, USA
Bigelow Laboratory with an investment of US$30 million plans to open a new advance ocean education and innovation centre
Cleveland Clinic Plans to Construct Research Building in USA
The stateoftheart facilities will be dedicated to enhance scientific investigations and expanding laboratory research space on its main campus
MaaT Pharma and Skyepharma Construct New Manufacturing Facility in Europe
MaaT Pharma and Skyepharma have successfully completed the construction of Europes largest manufacturing facility dedicated to microbiome ecosystem therapies
Astraea Bioseparations Expands Manufacturing and Warehousing Capacity in Massachusetts, USA
Astraea Bioseparations is expanding its manufacturing and warehousing capacity to support chromatography solutions in Massachusetts, USA
